OII statement on the use of dexamethasone during pregnancy

This is a policy statement by the global board of OII, and is endorsed by OII Australia.

We, the board members of the Organisation Intersex International, wish to express our support of Drs. Feder, Dreger and Lindemann, for their vigilance and efforts to ensure the safety of intersex infants and their mothers who are currently being prescribed dexamethasone.

We share their concerns about this experimental use of dexamethasone currently underway in the United States.

We would like our friends and allies to read the letter that Drs. Feder, Dreger and Lindemann have signed to request an investigation into this serious matter.

We thank them for their support and await the results of this enquiry, hoping that, whatever the outcome, intersex children and their parents will be granted their inalienable human rights and treated with all the dignity that any child and parent should expect.

For more information: